Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
34101
Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34102
Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34103
Epidural Hydromorphone for Postpartum Pain Management After Vaginal Delivery: A Randomized Clinical Trial
Published 2025“…Postpartum analgesic medication requirements were reduced in the HY group (6.79% vs. 24.77%; OR 0.39, 95% CI 0.25-0.61), and the time to first additional analgesic was prolonged (15.63 ± 5.98 vs. 12.01 ± 5.01 h). However, the HY group exhibited increased rates of nausea and vomiting (26.24% vs. 8.11%; RR 1.72, 95% CI 1.45-2.04), dizziness (25.34% vs. 14.41%; RR 1.34, 95% CI 1.13-1.66), pruritus (32.58% vs. 7.21%; RR 1.95, 95% CI 1.67-2.28), and urinary retention (20.81% vs. 7.66%; RR 1.59, 95% CI 1.32-1.91). …”
-
34104
Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34105
Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34106
Figure 3 from Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation
Published 2025“…<i>P</i> < 0.05, |log<sub>2</sub> fc| > log<sub>2</sub> (1.5)] modulated ones are indicated with name. Niraparib decreases CYP51A1 (lanosterol 14α-demethylase) enzyme levels (Supplementary Fig. …”
-
34107
Data Sheet 2_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34108
Data Sheet 10_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34109
Data Sheet 12_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34110
Data Sheet 6_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”
-
34111
Early dendritic protrusions of Fmr1 KO mice develop normally in vitro, except for a transiently elevated density at P4–7.
Published 2013“…Images are best projections (∼5–11 optical sections, 1 µm apart). Dendrites were imaged every 60 seconds, but only a subset of time points is shown. …”
-
34112
Table_1_How, when, and to what degree do people with alcohol dependence recover their psychological wellbeing and quality of life? The Madrid Recovery Project.DOCX
Published 2023“…</p>Results<p>In general, according to the regression models, there were pronounced increases in indices of wellbeing and coping strategies (and pronounced decreases in negative emotionality) during the first 5 years of abstinence, followed by less pronounced improvements. …”
-
34113
Datasheet3_Metabolic impact of feeding prior to a 60-min bout of moderate-intensity exercise in females in a fasted state.docx
Published 2023“…</p>Methods<p>Recreationally active females (n = 15, 32 ± 10 years, 164.8 ± 5.6 cm, 63.5 ± 9.3 kg, 23.4 ± 3.2 kg/m<sup>2</sup>) completed four testing sessions in a randomized, double-blind, crossover fashion after fasting overnight. …”
-
34114
Data Sheet 1_Top motor and non-motor complaints in patients with Parkinson's disease.docx
Published 2025“…The presence of non-motor symptoms in the top three tiers was associated with decreased cognitive status (MoCA <25 points), but not with age, sex, or disease evolution time. …”
-
34115
Effects of Physical Activity Training in Patients with Alzheimer’s Dementia: Results of a Pilot RCT Study
Published 2015“…</p><p>Methods</p><p>In an RCT thirty patients (aged 72.4±4.3 years) with AD (MMSE: 20.6±6.5 points) and their family caregivers were allocated to a home-based 12-week PA intervention program or the usual care group. …”
-
34116
Datasheet4_Metabolic impact of feeding prior to a 60-min bout of moderate-intensity exercise in females in a fasted state.docx
Published 2023“…</p>Methods<p>Recreationally active females (n = 15, 32 ± 10 years, 164.8 ± 5.6 cm, 63.5 ± 9.3 kg, 23.4 ± 3.2 kg/m<sup>2</sup>) completed four testing sessions in a randomized, double-blind, crossover fashion after fasting overnight. …”
-
34117
Image_1_The Role of Lactate Exercise Test and Fasting Plasma C-Peptide Levels in the Diagnosis of Mitochondrial Diabetes: Analysis of Clinical Characteristics of 12 Patients With M...
Published 2022“…In addition, patients with MD exhibited significantly higher mean plasma lactate levels immediately after exercise compared to patients with type 1 diabetes mellitus (T1DM) (8.39 ± 2.75 vs. 3.53 ± 1.47 mmol/L, p=0.003) and delayed recovery time after exercise (6.02 ± 2.65 vs. 2.17 ± 1.27 mmol/L, p=0.011). The optimal cut-off points identified were 5.5 and 3.4 mmol/L for plasma lactate levels immediately after and 30 minutes after exercise, respectively. …”
-
34118
Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
Published 2017“…Questionnaires were completed at 5 different time points. Patients were stratified into 5 subgroups according to the presence of PML risk factors (prior immunosuppression, anti-JCV antibody status, treatment duration). …”
-
34119
Datasheet1_Metabolic impact of feeding prior to a 60-min bout of moderate-intensity exercise in females in a fasted state.docx
Published 2023“…</p>Methods<p>Recreationally active females (n = 15, 32 ± 10 years, 164.8 ± 5.6 cm, 63.5 ± 9.3 kg, 23.4 ± 3.2 kg/m<sup>2</sup>) completed four testing sessions in a randomized, double-blind, crossover fashion after fasting overnight. …”
-
34120
In the CE3b-group, the AgB-specific IL-4 response changed over time independently of therapy.
Published 2021“…<p>Whole-blood test analysis at T1 (15 patients in the CE3b-group and in 14 patients in the CE4-group) and at T2 (5 patients in the CE3b-group and in 4 patients in the CE4-group). …”